Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 10:814:146134.
doi: 10.1016/j.gene.2021.146134. Epub 2022 Jan 4.

From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants

Affiliations
Review

From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants

Vasileios Papanikolaou et al. Gene. .

Abstract

Coronavirus-related Severe Acute Respiratory Syndrome (SARS-CoV) in 2002/2003, Middle-East Respiratory Syndrome (MERS-CoV) in 2012/2013, and especially the current 2019/2021 Severe Acute Respiratory Syndrome-2 (SARS-CoV-2) affected negatively the national health systems' endurance worldwide. SARS-Cov-2 virus belongs to lineage b of beta-CoVs demonstrating a strong phylogenetic similarity with BatCoVRaTG13 type. Spike (S) glycoprotein projections -consisting of two subunits S1/S2- provide a unique crown-like formation (corona) on virion's surface. Concerning their functional role, S1 represents the main receptor-binding domain (RBD), whereas S2 is involved in the virus-cell membrane fusion mechanism. On Nov 26th 2021, WHO designated the new SARS-CoV-2 strain - named Omicron, from letter ''όμικρον'' in the Greek alphabet - as a variant of concern (B.1.1529 variant). Potentially this new variant is associated with high transmissibility leading to elevated infectivity and probably increased re-infection rates. Its impact on morbidity/mortality remains under investigation. In the current paper, analyzing and comparing the alterations of SARS-CoV-2 S RNA sequences in the defined variants (Alpha to Omicron), we observed some interesting findings regarding the S1-RBD/S2 mutation/deletion equilibrium that maybe affect and modify its activity.

Keywords: COVID-19; Genome; Mutations; RNA; SARS-CoV-2; Variants.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Schematic, algorithmic representation of the SARS-CoV-2 variants landscape. Specific combinations of mutations and deletions are recognized. Critical deletions affect exclusively the non-RBD S1 region (ΔΗ69/ΔV70/Δ156/Δ157/ΔΥ144/ ΔL242/ΔΑ243/ΔL244) increasing virus transmission ability/infectivity affecting also negatively the immune response levels to neutralizing antibodies (decreased serum neutralization titles). D614G is the dominant and highly conserved substitution, whereas N501Y/ E484K-Q/ K417N/T/ L452R mutations are very important. del/ D614G/ E484Q combination in delta variant seems to be unique leading COVID-19 to a specific disease phenotype. A710V/V1176F/T716I/T1027/D1118H is the most important mutations in the S2 region. Omicron variant is characterized by an ‘’exotic’’ combination of many mutations, deletions and one novel insertion.

References

    1. Akkiz H. Implications of the novel mutations in the SARS-CoV-2 genome for transmission, disease severity, and the vaccine development. Front Med (Lausanne) 2021;8:636532–636539. doi: 10.3389/fmed.2021. - DOI - PMC - PubMed
    1. Ahmad Abu Turab Naqvia, Kisa Fatimab, Taj Mohammada, Urooj Fatimac, Indrakant K. Singhd, Archana Singhe, Shaikh Muhammad Atiff, Gururao Hariprasadg, Gulam Mustafa Hasanh, Md. Imtaiyaz Hassana (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim Biophys Acta Mol Basis Dis ; 1866(10): 165878. doi: 10/1016/j.bbadis.2020.165878. - PMC - PubMed
    1. Burki T. Understanding variants of SARS-CoV-2. Lancet. 2021;397:462–548. doi: 10.1016/S0140-6736(21)00298-1. - DOI - PMC - PubMed
    1. Boehm, E., Kronig, I., Neher, R.A., Eckerie, I., Vetter, P., Kaiser, L., 2021. Novel SARS-CoV-2 variants: the pandemic within the pandemic. Clin Microbiol Infect. S1198-743X(21) 00262-7. doi: 10.1016/j.cmi.2021.05.022. - PMC - PubMed
    1. Bal A., Destras G., Gaymard A., Stefic K., Marlet J., Eymieux S., Regue H., Semanas Q., d’Aubarede C., Billaud G., Laurent F., Gonzalez C., Mekki Y., Valette M., Bouscambert M., Gaudy-Graffin C., Lina B., Morfin F., Josset L. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, august to December 2020. Euro. Surveill. 2021;26(3) doi: 10.2807/1560-7917.ES.2021.26.3.2100008. - DOI - PMC - PubMed

Supplementary concepts